Israel-headquartered MDClone, maker of a Synthetic Data Engine for healthcare, has raised $26m in a Series B funding round led by aMoon, a VC fund focused on health tech and life sciences, it was announced this week. Existing backers OrbiMed Israel Partners and Lightspeed Venture Partners also participated in the raise.


According to MDClone, its engine examines original patient data and generates new datasets based only on statistics, containing no information that would risk exposing patient identity. The aim is to enable data to be accessed and analysed through the MDClone Healthcare Data Sandbox for quality improvement, research and innovation while protecting patient privacy.


In Israel, the startup, founded in 2016, boasts the Tel-Aviv Sourasky Medical Center and the Sheba Medical Center, which was recently named as one of the top 10 hospitals in the world by Newsweek, in its client portfolio. But MDClone has also recently expanded to the US, where it is working with Intermountain Healthcare, the Washington University School of Medicine in St Louis and the Regenstrief Institute in Indianapolis.

Announcing the new investment this week, MDClone said it would use the new funds to further develop its existing platform, build new products and accelerate growth.


In a recent study, the Start-Up Nation Centre identified nearly 540 digital health companies in Israel, where the healthcare system has been paperless for around 20 years now, as reported by MobiHealthNews editor-in-chief Jonah Comstock following a press trip to Tel-Aviv.

Investors are also taking notice, with Theranica, Israeli company developing advanced electroceuticals for migraine and other prevalent diseases, landing $35m and Aidoc, provider of AI solutions for radiology, $27 million in Series B funding.

In April, it was announced that Finland and Israel, countries both seen as booming hotspots for digital health, would work together to drive advances in the field, starting with a pilot project led by the Helsinki Business Hub and the Israeli Innovation Authority.


Commenting on the raise, Ziv Ofek, founder and chief executive of MDClone – who also founded dbMotion, which was bought by EHR giant Allscripts in 2013 for $235m, said in a statement:

“MDClone’s solution unlocks data and with the newly added power of aMoon and continued support from OrbiMed and Lightspeed, we can turn data into a real strategic asset to transform care around the world.”

Source : MobiHealthNews


Please enter your comment!
Please enter your name here